1. ScholarBank@NUS

Chen Chien-Shing

rp04354

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Chen Chien-Shing
(not current staff)
Variants
Khng, J.
Chen, C.-S.
Chen, C.S.
Zhou, J.
 
Main Affiliation
 
Faculty
 
Email
mdcccs@nus.edu.sg
 

Publications

Refined By:
Type:  Article

Results 1-18 of 18 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
12008ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograftJasinghe, V.J. ; Xie, Z. ; Zhou, J. ; Khng, J.; Poon, L.-F. ; Senthilnathan, P. ; Chen, C.-S. ; Albert, D.H.; Davidsen, S.K.
22009ABT-869, a promising multi-targeted tyrosine kinase inhibitor: From bench to bedsideZhou, J. ; Chen, C.-S. ; Goh, B.-C.; Albert, D.H.
32006Cleavage of misfolded nuclear receptor corepressor confers resistance to unfolded protein response-induced apoptosisNg, A.P.P.; Fong, J.H.; Nin, D.S.; Chen, C.-S. ; Pervaiz, S. ; Khan, M. ; Hirpara, J.L. ; Asou, N.
42009Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AMLZhou, J. ; Bi, C.; Janakakumara, J.V. ; Liu, S.-C.; Chng, W.-J.; Tay, K.-G. ; Poon, L.-F. ; Xie, Z. ; Palaniyandi, S. ; Chen, C.-S. ; Yu, H. ; Glaser, K.B.; Albert, D.H.; Davidsen, S.K.
52009Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AMLZhou, J. ; Bi, C.; Janakakumara, J.V. ; Liu, S.-C.; Chng, W.-J. ; Tay, K.-G. ; Poon, L.-F. ; Xie, Z. ; Palaniyandi, S. ; Chen, C.-S. ; Yu, H. ; Glaser, K.B.; Albert, D.H.; Davidsen, S.K.
62006Gene expression profiling in R-flurbiprofen-treated prostate cancer: R-Flurbiprofen regulates prostate stem cell antigen through activation of AKT kinaseZemskova, M.; Bashkirova, S.; Lilly, M.B.; Wechter, W.; Chen, C.-S. ; Reiter, R.
72007Impact of Postgrafting Immunosuppressive Regimens on Nonrelapse Mortality and Survival after Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant Using the Fludarabine and Low-Dose Total-Body Irradiation 200-cGyKoh, L.-P.; Hwang, W.Y.K.; Linn, Y.-C.; Koh, M.B.C.; Goh, Y.-T.; Ng, H.-J.; Loh, Y.S.M.; Tan, D.C.L.; Ng, H.-Y.; Tan, K.-W.; Chen, C.-S. ; Tan, L.-K.; Tan, B.; Lim, S. ; Lee, Y.-M.; Liu, T.-C.; Mow, B.M.F.; Tai, B.-C. ; Tan, P.H.C.
82008In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptorZhou, J. ; Khng, J.; Jasinghe, V.J. ; Bi, C.; Poon, L.F. ; Xie, Z. ; Chen, C.-S. ; Neo, C.H.S.; Pan, M.; Yu, H. ; Yeoh, A.E.-J.; Lu, Y. ; Glaser, K.B.; Albert, D.H.; Davidsen, S.K.
92008In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptorZhou, J. ; Khng, J.; Jasinghe, V.J. ; Bi, C.; Poon, L.F. ; Xie, Z. ; Chen, C.-S. ; Neo, C.H.S.; Pan, M.; Yu, H. ; Yeoh, A.E.-J. ; Lu, Y. ; Glaser, K.B.; Albert, D.H.; Davidsen, S.K.
102008In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptorZhou, J. ; Khng, J.; Jasinghe, V.J.; Bi, C.; Poon, L.F.; Xie, Z. ; Chen, C.-S. ; Neo, C.H.S.; Pan, M.; Yu, H. ; Yeoh, A.E.-J.; Lu, Y. ; Glaser, K.B.; Albert, D.H.; Davidsen, S.K.
112008Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasionXie, Z. ; Choong, P.F. ; Poon, L.F. ; Zhou, J. ; Khng, J. ; Jasinghe, V.J. ; Palaniyandi, S. ; Chen, C.-S. 
122007Molecular response of leukemia HL-60 cells to genistein treatment, a proteomics studyZhang, D. ; Koay, E.S.-C. ; Tai, Y.-C. ; Wong, C.-H.S. ; Chen, C.-S. ; Tai, L.-K. 
132007Molecular response of leukemia HL-60 cells to genistein treatment, a proteomics studyZhang, D. ; Koay, E.S.-C. ; Tai, Y.-C. ; Wong, C.-H.S.; Chen, C.-S. ; Tai, L.-K. 
142008Potential roles for the PIM1 kinase in human cancer - A molecular and therapeutic appraisalShah, N. ; Yeoh, K.-G. ; Chen, C.S. ; Salto-Tellez, M. ; Thorn, S.; Lilly, M.B.
152007Progressive loss of epidermal growth factor receptor in a subpopulation of breast cancers: Implications in target-directed therapeuticsChoong, L.-Y. ; Lim, S. ; Man, X. ; Chen, Y. ; Toy, W. ; Pan, M. ; Chen, C.-S. ; Salto-Tellez, M. ; Shah, N. ; Lim, Y.-P.; Poonepalli, A. ; Hande, M.P. ; Tan, P.-H. ; Wong, C.-Y.; Loh, M.C.-S.; Druker, B.J.
162007Synergistic antileukemia effect of genistein and chemotherapy in mouse xenograft model and potential mechanism through MAPK signalingShen, J.; Tai, Y.-C. ; Zhou, J. ; Stephen, Wong C.-H. ; Xie, Z. ; Chen, C.-S. ; Cheang, P.T.S. ; Han, J.-H. ; Fred, Wong W.-S. ; Khan, M. 
172007Therapeutic targeting of nuclear receptor corepressor misfolding in acute promyelocytic leukemia cells with genisteinNg, A.P.P. ; Nin, D.S.; Fong, J.H.; Venkataraman, D.; Khan, M. ; Chen, C.-S. 
182010Time-dependent dynamic mobilization of circulating progenitor cells during percutaneous coronary intervention in diabeticsLee, L.C.; Low, A. ; Tan, H.C. ; Poh, K.K. ; Chen, C.-S. ; Choong, P.-F.